Southern medical journal
-
Southern medical journal · May 2001
Randomized Controlled Trial Clinical TrialNew polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study.
This study evaluated the safety and effectiveness of a new polyethylene glycol (PEG) laxative (MiraLax, Braintree Laboratories Inc, Braintree, Mass) in 23 patients reporting a history of constipation. ⋯ Daily therapy with 17 g of PEG laxative for 14 days resulted in a significant improvement in bowel movement frequency in constipated patients relative to placebo by the second week of treatment.